1.
Drelichman G, Fernández Escobar N, Soberón B, Basack N, Aversa L, Watman N, Bolesina M, Ávila M, Dragosky M, Jozami C, Larroudé M, Aguilar G, Rossi I, Schenone A. Eliglustat, a new substrate reduction therapy for adult patients with Gaucher disease type 1: effectiveness at 6 years evaluated in three centers of Argentine. RH [Internet]. 2019 Dec. 31 [cited 2026 Nov. 18];23(3):25-34. Available from: https://mail.revistahematologia.com.ar/index.php/Revista/article/view/215